Published: 3 September 2026
Publications
Quarterly summary of recent safety communications
Published: 3 September 2026
Prescriber Update 47(3): 43
September 2026
The table below is a summary of recent safety communications for healthcare professionals and consumers. Click on a specific topic to go to the communication.
| Date | Communication | Topic |
|---|---|---|
| 24/08/2026 | Consultation outcome | Outcome of the consultation on changes to clozapine blood monitoring and prescribing requirements |
| 03/08/2026 | Advisory | Nitrous oxide advisory (August 2026 update) |
| 28/07/2026 | Monitoring | Update - Atomoxetine and the possible risk of gynaecomastia |
| 25/06/2026 | Alert | Product Alert of Dexcom US G7 Sensors: Lots 1725204004 and 1725069002 |
| 16/06/2026 | Alert | Recall of The Good Vitamin Co Kids Good Multi gummies (Kids Good Multi): Batches GV011015, GV011017V and GV011018V |
| 02/06/2026 | Dear Healthcare Professional Letter | Sumagran (sumatriptan succinate) 100 mg film coated tablets – NZ-Specific Cartons with “Dutch” Foils |
| 02/06/2026 | Dear Healthcare Professional Letter | Benzetacil (benzathine benzylpenicillin): Shortage of Bicillin L-A and alternative supply of Benzetacil (PDF, 3 pages, 260 KB) |
Note that sponsors write Dear Healthcare Professional Letters and distribute them to relevant healthcare professionals. Medsafe publishes copies of these letters on the Medsafe website.
